Compare SANA & ADAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SANA | ADAM |
|---|---|---|
| Founded | 2018 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.1M | 826.7M |
| IPO Year | 2021 | 2003 |
| Metric | SANA | ADAM |
|---|---|---|
| Price | $2.90 | $7.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | $8.43 | ★ $12.13 |
| AVG Volume (30 Days) | ★ 3.4M | 1.0M |
| Earning Date | 11-05-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 13.88% |
| EPS Growth | 17.24 | ★ 196.49 |
| EPS | N/A | ★ 0.87 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.19 |
| P/E Ratio | ★ N/A | $9.14 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.61 | $6.45 |
| 52 Week High | $6.55 | $10.36 |
| Indicator | SANA | ADAM |
|---|---|---|
| Relative Strength Index (RSI) | 36.78 | 13.63 |
| Support Level | $2.64 | $7.09 |
| Resistance Level | $3.41 | $7.80 |
| Average True Range (ATR) | 0.17 | 0.21 |
| MACD | -0.02 | -0.12 |
| Stochastic Oscillator | 11.77 | 1.33 |
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.